Home › Bids
› Exploratory Clinical Trial Grants in Arthritis and Musculosk
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Open201 days leftHealthcaregrant
Dec 9, 2024
Nov 2, 2026 12:00 AM
Healthcare
grant
...
AI Summary
This grant opportunity, PAR-24-279 (CFDA: 93.846), funds exploratory clinical trials in arthritis, musculoskeletal, and skin diseases. It requires an R61 clinical trial.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.